Your browser doesn't support javascript.
loading
Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients-authors' reply.
Volkers, Adriaan; Straatmijer, Tessa; Duijvestein, Marjolijn; Löwenberg, Mark; van der Meulen, Andrea; D'Haens, Geert.
Afiliação
  • Volkers A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Straatmijer T; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Duijvestein M; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
  • Löwenberg M; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • van der Meulen A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • D'Haens G; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
Aliment Pharmacol Ther ; 57(6): 743-744, 2023 03.
Article em En | MEDLINE | ID: mdl-36821751
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article